🇺🇸 FDA
Patent

US 7687610

Human chorionic gonadotropin superagonists

granted A61KA61K38/00

Quick answer

US patent 7687610 (Human chorionic gonadotropin superagonists) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
50
CPC classes
A61K, A61K38/00